Severe, persistent, and fatal T-cell immunodeficiency following therapy for infantile leukemia

Ashley V Geerlinks1, Thomas Issekutz2, Justin T Wahlstrom3

  • 1Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. Ashley.geerlinks@iwk.nshealth.ca.

Insights

Infants completing chemotherapy for acute lymphoblastic leukemia (ALL) can develop severe T-cell immunodeficiency. This serious complication requires early consideration in ALL survivors to prevent opportunistic infections and mortality.

Area of Science:

  • Pediatric Oncology
  • Immunology
  • Hematology

Background:

  • Infantile acute lymphoblastic leukemia (ALL) requires intensive chemotherapy regimens.
  • Post-chemotherapy immune recovery can be complex in pediatric patients.

Observation:

  • Five children diagnosed with severe T-cell immunodeficiency post-chemotherapy for infantile ALL.
  • Observed near absence of CD3(+), CD4(+), and CD8(+) T-cells.
  • Patients exhibited varying B-cell and NK-cell depletion.

Findings:

  • All affected children developed multiple opportunistic infections.
  • Four out of five patients succumbed to the condition.
  • One patient achieved successful recovery through hematopoietic stem cell transplantation.

Implications:

  • Chemotherapy for infantile ALL can precipitate life-threatening secondary immunodeficiencies.
  • Early recognition and management of T-cell depletion are crucial for ALL survivors.
  • Hematopoietic stem cell transplantation offers a potential treatment avenue for severe cases.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
85.9K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
5
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K